These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 29017498)
1. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients. Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498 [TBL] [Abstract][Full Text] [Related]
2. Variability in glycated albumin levels predicts the progression of diabetic nephropathy. Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158 [TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes. Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356 [TBL] [Abstract][Full Text] [Related]
4. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus. Wang N; Xu Z; Han P; Li T Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245 [TBL] [Abstract][Full Text] [Related]
5. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence. Sany D; Elshahawy Y; Anwar W Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348 [TBL] [Abstract][Full Text] [Related]
6. Glycated albumin indicates peripheral diabetic neuropathy. Wang N; Guo C; Han P; Li T Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202 [TBL] [Abstract][Full Text] [Related]
7. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study. Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934 [TBL] [Abstract][Full Text] [Related]
8. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Jun JE; Jin SM; Baek J; Oh S; Hur KY; Lee MS; Lee MK; Kim JH Cardiovasc Diabetol; 2015 Jun; 14():70. PubMed ID: 26041130 [TBL] [Abstract][Full Text] [Related]
9. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis. Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952 [TBL] [Abstract][Full Text] [Related]
10. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. Koga M; Murai J; Morita S; Saito H; Kasayama S J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788 [TBL] [Abstract][Full Text] [Related]
11. Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study. Tang M; Berg AH; Zheng H; Rhee EP; Allegretti AS; Nigwekar SU; Karumanchi SA; Lash JP; Kalim S Am J Kidney Dis; 2024 Sep; 84(3):329-338. PubMed ID: 38518919 [TBL] [Abstract][Full Text] [Related]
12. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report. Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695 [TBL] [Abstract][Full Text] [Related]
13. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819 [TBL] [Abstract][Full Text] [Related]
14. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Matsumoto H; Murase-Mishiba Y; Yamamoto N; Sugitatsu-Nakatsukasa S; Shibasaki S; Sano H; Terasaki J; Imagawa A; Hanafusa T Intern Med; 2012; 51(11):1315-21. PubMed ID: 22687835 [TBL] [Abstract][Full Text] [Related]
15. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival. Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T; Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784 [TBL] [Abstract][Full Text] [Related]
16. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Okada T; Nakao T; Matsumoto H; Shino T; Nagaoka Y; Tomaru R; Wada T Intern Med; 2007; 46(12):807-14. PubMed ID: 17575371 [TBL] [Abstract][Full Text] [Related]
17. Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea. Shin KS; Park MS; Lee MY; Cho EH; Woo HY; Park H; Kwon MJ Scand J Clin Lab Invest; 2024 May; 84(3):168-173. PubMed ID: 38634263 [TBL] [Abstract][Full Text] [Related]
18. Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease. Shen Y; Dai D; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J Cardiovasc Diabetol; 2020 Dec; 19(1):211. PubMed ID: 33302958 [TBL] [Abstract][Full Text] [Related]
19. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study. Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717 [TBL] [Abstract][Full Text] [Related]
20. Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome. Kitamura T; Otsuki M; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Bando Y; Shimomura I; Koga M Clin Biochem; 2014 Dec; 47(18):279-82. PubMed ID: 25218816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]